Skip to main content
Clinical Trials/NCT02776345
NCT02776345
Unknown
Not Applicable

Study to Evaluate Ultrasound Guided Interventions of Calcific Tendonitis of Rotator Cuff- International CollabratioN (SUCTION)

Hamilton Health Sciences Corporation1 site in 1 country160 target enrollmentMarch 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rotator Cuff Calcific Tendonitis
Sponsor
Hamilton Health Sciences Corporation
Enrollment
160
Locations
1
Primary Endpoint
Decrease in Pain as measured by the Visual analog scale from 1-10
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to determine whether minimally invasive treatments like ultrasound guided needle fragmentation with and without lavage is associated with better clinical outcomes compared to the subacromial bursal corticosteroid injection treatment only.

Detailed Description

The objectives of this study are to compare the clinical outcomes of the three treatment arms: ultrasound guided needle fragmentation with lavage, ultrasound guided needle fragmentation without lavage, and subacromial bursal corticosteroid injection treatment. The study design is a randomized control trial.

Registry
clinicaltrials.gov
Start Date
March 2021
End Date
April 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hema Choudur

Associate Professor, Department of Radiology

Hamilton Health Sciences Corporation

Eligibility Criteria

Inclusion Criteria

  • Adult men or women ages 18 to 60 years
  • Shoulder pain ( including impingement pain) and reduced range of shoulder movement for greater than 6 months with no relief from non-operative means (physiotherapy, nonsteroidal anti-inflammatory medication, rest).
  • Documentation of failed physiotherapy and conservative management.
  • Calcific tendonitis as diagnosed on ultrasound.
  • Informed consent from participant.
  • Ability to speak, understand and read in the language of the clinical site.

Exclusion Criteria

  • Previous inclusion in a study involving calcific tendonitis of the rotator cuff
  • Evidence of a calcification in any of the rotator cuff tendons except the supraspinatus tendon.
  • Presence of a tear of the rotator cuff.
  • The supraspinatus tendon calcification is more than 1.5 cm is its largest dimension.
  • Concomitant clinical or MRI diagnosis of frozen shoulder.
  • Previous rotator cuff or shoulder surgery.
  • Those on blood thinners.
  • Those with allergies to medication used.
  • Those with a skin infection at the site of needle entry.
  • Immunosuppressive medication use.

Outcomes

Primary Outcomes

Decrease in Pain as measured by the Visual analog scale from 1-10

Time Frame: 8 months

Pain in the original symptomatic area of the rotator cuff will be reassessed using the visual analog scale from 1-10 (1 being the lowest pain and 10 being the highest)

Decreased Range of Motion in the shoulder measured in degrees

Time Frame: 8 months

Abduction, internal rotation, external rotation and circumduction of the shoulder

Secondary Outcomes

  • Costs and health resource utilization as measured by administrative and billing data related to treatment(Up to 8-12 months post surgery)
  • Complications and co existing conditions not detected prior to the procedure(Post ultrasound guided procedure through completion of study, up to one year)
  • Generic physical and mental health as measured by EuroQol(Up to 8-12 months post surgery)
  • The ultrasound appearance of the targeted calcification(Up to 8-12 months post surgery)

Study Sites (1)

Loading locations...

Similar Trials